In Brief | Critical Care, Anaesthesia & Emergency Medicine | Paediatrics & Neonatology
Early Epinephrine Use Reduces ICU Admissions in Children with Anaphylaxis
Time to read: 03:47
Time to listen: 07:45
Published on MedED: 12February 2025
Originally Published: 20 December 2024
Source: The Journal of Allergy and Clinical Immunology: In Practice
Type of article: In Brief
MedED Catalogue Reference: MPIB0021
Category:Emergency Medicine
Cross Reference: Paediatrics & Neonatoloy, Allergy
Keywords: allergy, anaphalyxix, critical care, emergency medicine, epiniepherine
Top
This article is a review of recent studies originally published in the Journal of Allergy and Clinical Immunology: In Practice, 20 December 2024. This article does not represent the original research, nor is it intended to replace the original research. Access the full Disclaimer Information.
Epinephrine is the first-line treatment for anaphylaxis; however, its direct impact on paediatric patient outcomes, such as ICU admissions, remains unclear, in part due to confounding factors.
This study, published in The Journal of Allergy and Clinical Immunology: In Practice on 20 December 2024, aimed to determine the effect of outpatient (prehospital) epinephrine use on hospital outcomes in paediatric patients, particularly intensive care unit (ICU) admissions, by using propensity score matching (PSM) to minimise confounding biases.
Study Purpose
The primary objective of this study was to assess whether the administration of outpatient epinephrine reduces hospital and ICU admissions in children with anaphylaxis.
The study also sought to compare the outcomes of patients who received outpatient epinephrine versus those who did not while accounting for confounding variables through PSM. Additionally, outpatient antihistamine use was analyzed as a negative control to ensure that observed effects were specific to epinephrine.
The researchers state that their knowledge is the first study that used PSM to establish the association between outpatient epinephrine and hospital outcomes in anaphylaxis.
Study Methodology
The study included children aged 0–18 years who presented with anaphylaxis at the Montreal Children’s Hospital (MCH) from April 2011 to November 2023.
Anaphylaxis was defined as a reaction involving at least two organ systems and/or hypotension using Food Allergy & Anaphylaxis Network/National Institute Allergy and Infectious Disease (FAAN/NIAID) criteria.
Data were collected both prospectively and retrospectively, encompassing demographics, severity of symptoms, comorbidities, and reaction locations.
Propensity score matching (PSM) was used to balance confounders such as age, sex, asthma, food allergy, reaction location, and severity.
Matching was performed in a 1:1 ratio using nearest-neighbour matching. The statistical analysis included chi-square tests for categorical variables and unpaired t-tests for continuous variables using R software.
Findings
A total of 3,158 paediatric patients presenting with anaphylaxis were included in the review.
1,388 (44.0%) received outpatient epinephrine and 1,770 (56.0%) did not.
Significant differences were observed between the groups before matching:
- Patients who received outpatient epinephrine were older (median age 7.3 vs. 5.0 years; p = 0.01).
- Known food allergy (79.0% vs. 42.8%; p = 0.01) and asthma (18.6% vs. 13.9%; p = 0.01) were more prevalent in those who received epinephrine.
- These patients were less likely to receive outpatient antihistamines (41.6% vs. 45.8%; p = 0.01) but more likely to receive corticosteroids (2.2% vs. 0.9%; p = 0.01)
Regarding hospital outcomes:
- ICU admissions were significantly lower in the outpatient epinephrine group (0.7% vs. 1.6%; p = 0.03).
- No significant difference was observed in hospital ward admissions (1.0% vs. 0.6%; p = 0.30).The negative control analysis of outpatient antihistamines did not show a significant impact on hospital outcomes, supporting the specificity of the epinephrine effect.
-
Conclusion
This study confirms that outpatient epinephrine use significantly reduces ICU admissions in children with anaphylaxis. Despite its well-documented efficacy, under-utilisation of epinephrine remains a concern. These findings highlight the urgent need for enhanced education and training among caregivers and healthcare professionals to ensure the timely administration of epinephrine in anaphylactic emergencies.
Access the original study
Khalaf, R., Prosty, C., Clarke, A. E., McCusker, C., Bretholz, A., & Ben-Shoshan, M. (2024). Outpatient epinephrine administration reduces ICU admission rates in anaphylactic reactions: a propensity score-matched cohort. The journal of allergy and clinical immunology. In practice, S2213-2198(24)01263-7. Advance online publication. https://doi.org/10.1016/j.jaip.2024.12.020
Additional References
1. Chippendale, S. E., Reichmuth, K., Worm, M., & Levin, M. (2022). Paediatric anaphylaxis in South Africa. The World Allergy Organization journal, 15(9), 100666. https://doi.org/10.1016/j.waojou.2022.100666
Back to top
Disclaimer
This article is compiled from several resources researched and compiled by the contributor. It is in no way presented as an original work. Every effort has been made to attribute quotes and content correctly. Where possible all information has been independently verified. The Medical Education Network bears no responsibility for any inaccuracies which may occur from the use of third-party sources. If you have any queries regarding this article contact us
Fact-checking Policy
The Medical Education Network makes every effort to review and fact-check the articles used as source material in our summaries and original material. We have strict guidelines in relation to the publications we use as our source data, favouring peer-reviewed research wherever possible. Every effort is made to ensure that the information contained here is an accurate reflection of the original material. Should you find inaccuracies, out of date content or have any additional issues with our articles, please make use of the contact us form to notify us.